Our recommendations help practitioners and commissioners get the best care to people, fast, while ensuring value for the taxpayer.
People in England with severe sickle cell disease will be among the first to receive treatment using revolutionary CRISPR gene editing technology, following publication of our final draft guidance today.
Consultation launches on the biggest shake-up of NICE's HealthTech programme to date.
We've recommended an innovative daily tablet treatment shown to reduce symptoms and improve quality of life.
The recommendation is included in our first clinical guideline on gambling-related harms: identification, assessment and management.
Best practice resources for practitioners and commissioners.
Useful sources of information and advice for healthcare professionals, patients, parents and carers.
Summaries of evidence and advice on common health topics (CKS)
On NICE’s 25th anniversary, our partners and collaborators in the health care system discuss what the future holds for NICE.
